Biologically Similar but Competitively Not So? Economic Considerations of IP Litigation Settlements Involving Biosimilars

#172 Biologically Similar but Competitively Not So? Economic Considerations of IP Litigation Settlements Involving Biosimilars

Under the U.S. Supreme Court case FTC v. Actavis (2013), antitrust analysis of “reverse settlements” […]

Jing He, Founder, GEN Law Firm

#128 When Will It Be the End of Global Anti-Suit Injunction Wars? Present & Prospective FRAND Litigation & Arbitration in China

As Chinese courts and authorities take on active roles in resolving FRAND disputes, China has […]

Jorge L. Contreras, Professor, S.J. Quinney College of Law, University of Utah

#127 Does the FRAND Framework Need a Fix?: Conversation With Prof. Jorge Contreras About Antitrust and IP

Complex issues are at the intersection of antitrust and intellectual property laws, and licensing of […]